renal and nonrenal cancer patients with pre-therapy serum creatinine levels of 1.0 to 1.4 mg. per dl . achieved similar high values in cycle 2 of interleukin-2 therapy ( 3.9 +/- 0.3 versus 3.9 +/- 0.4 mg. per dl . and 222.7 +/- 23.2 versus 248.7 +/- 33.5 per cent , respectively ) , although the initial increase ( cycle 1 ) was higher in the renal cancer patients ( 3.3 +/- 0.3 versus 2.4 +/- 0.2 mg. per dl . and 172.3 +/- 25.9 versus 116.1 +/- 18.0 per cent , respectively ) .
C0022646
renal
C0740457
renal cancer